Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lymphoma, Large B-Cell, Diffuse 43Breast Neoplasms 30Lymphoma 28Sarcoma 26Hodgkin Disease 24Triple Negative Breast Neoplasms 20Burkitt Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 16Neoplasms 15Ovarian Neoplasms 14Lymphoma, Non-Hodgkin 13Lymphoma, B-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell, Peripheral 9Endometrial Neoplasms 9Neuroblastoma 7Neoplasm Metastasis 7Lymphoma, Mantle-Cell 7Liposarcoma 7Leukemia 7Fallopian Tube Neoplasms 7Recurrence 6Multiple Myeloma 6Leiomyosarcoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Inflammatory Breast Neoplasms 5Histiocytoma, Malignant Fibrous 5

Interventions

pembrolizumab 4Cyclophosphamide 4Radiotherapy 3Cisplatin 3fludarabine 2Doxorubicin 2Carboplatin 2zimberelimab 1olaparib 1lenvatinib 1envafolimab 1avelumab 1Thymectomy 1Taxes 1Sunitinib 1Robotic Surgical Procedures 1Ramucirumab 1Radiotherapy, Adjuvant 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Etoposide 1Drug Therapy 1Chemoradiotherapy 1Cetuximab 1AP 1903 reagent 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thymoma × Doxorubicin × 1 year × Clear all
NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3 Not yet recruiting
116 enrolled
Thoracic

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

NCT01025089 2026-01-07

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
18 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡